Ausgewählte Publikationen
Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kubicka S,Luk JM, Schirmacher P, McCombie WR, Wigler M, Hicks J, Hannon GJ, Powers S, Lowe SW. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors inliver cancer. 2008 Nov 28;135(5):852-64. Epub 2008 Nov 13. PubMed PMID: 19012953.
Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H,Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. . 2008 Aug 22;134(4):657-67. PubMed PMID: 18724938
Xue W*, Zender L*, Miething C, Dickins RA, Hernando E, Krizhanovsky V,Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53restoration in murine liver carcinomas. . 2007 Feb 8;445(7128):656-60. Epub2007 Jan 24. PubMed PMID: 17251933.(*equal contribution).
Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, LukJM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. . 2006 Jun 30;125(7):1253-67. PubMed PMID: 16814713
Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, SingerS, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. DLC1 is a chromosome 8ptumor suppressor whose loss promotes hepatocellular carcinoma. . 2008 Jun 1;22(11):1439-44. PubMed PMID: 18519636; PubMed Central PMCID: PMC2418580.
